Chemotherapy Dose Adjustment for Obese Patients Undergoing Hematopoietic Stem Cell Transplantation: A Survey on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

BACKGROUND. Appropriate chemotherapy dosing for obese patients with malignant diseases is a significant challenge because limiting chemotherapy doses in these patients may negatively influence outcome. There is a paucity of information addressing high-dose chemotherapy in obese patients undergoing h...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncologist
Autores principales: Shem-Tov, Noga, Labopin, Myriam, Moukhtari, Leila, Ciceri, Fabio, Esteve, Jordi, Giebel, Sebastian, Gorin, Norbert-Claude, Schmid, Christopher, Shimoni, Avichai, Nagler, Arnon, Mohty, Mohamad
Formato: Artigo
Lenguaje:Inglês
Publicado: AlphaMed Press 2015
Materias:
Leukemias
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4294603/
https://ncbi.nlm.nih.gov/pubmed/25480827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0187
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares